Inhibition of phosphodiesterase 2 increases neuronal cGMP, synaptic plasticity and memory performance

被引:259
作者
Boess, FG
Hendrix, M [1 ]
van der Staay, FJ
Erb, C
Schreiber, R
van Staveren, W
de Vente, J
Prickaerts, J
Blokland, A
Koenig, G
机构
[1] Bayer HealthCare, Forschungszentrum Aprather Weg, D-42096 Wuppertal, Germany
[2] Bayer HealthCare, Pharma Res CNS, D-42096 Wuppertal, Germany
[3] Univ Maastricht, Dept Psychiat & Neuropsychol, NL-6200 MD Maastricht, Netherlands
[4] Univ Maastricht, Dept Neurocognit, NL-6200 MD Maastricht, Netherlands
关键词
phosphodiesterase; 2; PDE2; cGMP; long-term potentiation; LTP; memory; learning;
D O I
10.1016/j.neuropharm.2004.07.040
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
An essential element of the signalling cascade leading to synaptic plasticity is the intracellular second messenger molecule guanosine 3',5'-cyclic monophosphate (cGMP). Using the novel, potent, and selective inhibitor Bay 60-7550, we show that the enzyme 3',5'-cyclic nucleotide phosphodiesterase type 2 (PDE2) is responsible for the degradation of newly synthesized cGMP in cultured neurons and hippocampal slices. Inhibition of PDE2 enhanced long-term potentiation of synaptic transmission without altering basal synaptic transmission. Inhibition of PDE2 also improved the performance of rats in social and object recognition memory tasks, and reversed MK801-induced deficits in spontaneous alternation in mice in a T-maze. Our data provide strong evidence that inhibition of PDE2 can improve memory functions by enhancing neuronal plasticity. (C) 2004 Elsevier Ltd. All rights reserved.
引用
收藏
页码:1081 / 1092
页数:12
相关论文
共 74 条
[1]   cGMP and S-nitrosylation: two routes for modulation of neuronal excitability by NO [J].
Ahern, GP ;
Klyachko, VA ;
Jackson, MB .
TRENDS IN NEUROSCIENCES, 2002, 25 (10) :510-517
[2]   ACTIVITY-DEPENDENT LONG-TERM ENHANCEMENT OF TRANSMITTER RELEASE BY PRESYNAPTIC 3',5'-CYCLIC GMP IN CULTURED HIPPOCAMPAL-NEURONS [J].
ARANCIO, O ;
KANDEL, ER ;
HAWKINS, RD .
NATURE, 1995, 376 (6535) :74-80
[3]   Presynaptic role of cGMP-dependent protein kinase during long-lasting potentiation [J].
Arancio, O ;
Antonova, I ;
Gambaryan, S ;
Lohmann, SM ;
Wood, JS ;
Lawrence, DS ;
Hawkins, RD .
JOURNAL OF NEUROSCIENCE, 2001, 21 (01) :143-149
[4]   β-amyloid peptides decrease soluble guanylyl cyclase expression in astroglial cells [J].
Baltrons, MA ;
Pedraza, CE ;
Heneka, MT ;
García, A .
NEUROBIOLOGY OF DISEASE, 2002, 10 (02) :139-149
[5]   Effects of sildenafil on long-term retention of an inhibitory avoidance response in mice [J].
Baratti, CM ;
Boccia, MM .
BEHAVIOURAL PHARMACOLOGY, 1999, 10 (08) :731-737
[6]   Nerve growth factor inhibits PC12 cell PDE 2 phosphodiesterase activity and increases PDE 2 binding to phosphoproteins [J].
Bentley, JK ;
Juilfs, DM ;
Uhler, MD .
JOURNAL OF NEUROCHEMISTRY, 2001, 76 (04) :1252-1263
[7]   Hippocampal cGMP and cAMP are differentially involved in memory processing of inhibitory avoidance learning [J].
Bernabeu, R ;
Schmitz, P ;
Faillace, MP ;
Izquierdo, I ;
Medina, JH .
NEUROREPORT, 1996, 7 (02) :585-588
[8]   Functional and radioligand binding characterization of rat 5-HT6 receptors stably expressed in HEK293 cells [J].
Boess, FG ;
Monsma, FJ ;
Carolo, C ;
Meyer, V ;
Rudler, A ;
Zwingelstein, C ;
Sleight, AJ .
NEUROPHARMACOLOGY, 1997, 36 (4-5) :713-720
[9]   Analysis of the ligand binding site of the 5-HT3 receptor using site directed mutagenesis: Importance of glutamate 106 [J].
Boess, FG ;
Steward, LJ ;
Steele, JA ;
Liu, D ;
Reid, J ;
Glencorse, TA ;
Martin, IL .
NEUROPHARMACOLOGY, 1997, 36 (4-5) :637-647
[10]   POSSIBLE INVOLVEMENT OF NITRIC-OXIDE IN LONG-TERM POTENTIATION [J].
BOHME, GA ;
BON, C ;
STUTZMANN, JM ;
DOBLE, A ;
BLANCHARD, JC .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1991, 199 (03) :379-381